Skip to content

Study on the Application Value of Needle-based Confocal Laser Endomicroscopy-Assisted CT-Guided Percutaneous Biopsy in Lung Lesions

Study on the Application Value of Needle-based Confocal Laser Endomicroscopy-Assisted CT-Guided Percutaneous Biopsy in Lung Lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100280
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Lesions

Interventions

Sponsors

?Chinese PLA General Hospital First Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-80 years old; 2. Patients who have been evaluated by clinical and interventional experts as requiring and accepting CT guided percutaneous biopsy of lung lesions; 3. Patients with high clinical or imaging suspicion of lung cancer; 4. Patients who can obtain pathological conclusions after surgery; 5. Willing to sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals with coagulation dysfunction; 2.Pregnant or lactating women; 3.Individuals with severe liver and kidney dysfunction; 4.Due to various reasons, CLE image acquisition was not carried out by the person; 5. Known risk factors for allergies or allergic reactions to fluorescein; 6.Asthma patients;7.Undergoing chemotherapy because several chemotherapy drugs have fluorescent properties at the same wavelength (e.g. doxorubicin);8.Other researchers believe that patients who are not suitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
nCLE image features of lung lesions;Consistency between nCLE diagnosis and pathological conclusions;

Secondary

MeasureTime frame
Area Under Curve,AUC;Sensitivity;Specificity;Positive predictive value;Negative predictive value;

Countries

China

Contacts

Public ContactYueyong Xiao

?Chinese PLA General Hospital First Medical Center

xiaoyueyong@vip.sin.com+86 139 1171 0987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026